Gutiérrez MG, Cuevas SF, Castillo CRA, Murata C

Language: Spanish
References: 9
Page: 78-82
PDF size: 187.91 Kb.

ABSTRACT

Introduction: Asthma is the most frequent chronic lung disease in the pediatric patient with an average world prevalence of 17%. The role of the doctor in the treatment of the disease begins with early diagnosis and good control of it. A tool to achieve control is the educational aspect; the hypothesis of this study was that by being more informed parents and patients will have better control, clinically and functionally assessed according to the established criteria of GINA through ACT. Objective: To determine the impact of the Educational Program in the control of the disease in patients diagnosed with asthma. Material and methods: Design of the quasi-experimental, prospective, longitudinal and comparative study (pre-post). Prior informed consent of the parents included patients between five to 18 years, the ACT survey was applied at the beginning of the study and monthly, three educational sessions were given in the course of six months, with a duration of 90 minutes. Results: We analyzed the change of the categories of diagnosis of severity between baseline and final measurement during the months of July to November through correspondence analysis. The patients classified in the basal measurement with intermittent asthma (AI) the great majority remained in it, several patients changed to this category during the development of the study, the category of moderate persistent asthma (AMP) changed to mild persistent asthma (ALP) and disappears cases that were initially classified in the persistent severe asthma (ASP) category. Conclusion: The educational program favors the control of asthmatic disease.

REFERENCES

1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J [Internet]. 2018; 31 (1): 143-178. Available from: http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=118972966&site=ehost-live

2. Beasley R, Keil U, Von Mutius E, Pearce N. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet [Internet]. 1998; 351 (9111): 1225-1232. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9643741

3. Larenas-Linnemann D, Salas-Hernández J, Vázquez-García JC, Ortiz-Aldana I, Fernández-Vega M, Río-Navarro BE et al. Guía mexicana del asma: GUIMA 2017. Rev Alerg Mex. 2017; 64: s11-128.

4. Hill RA, Standen PJ, Tattersfield AE. Asthma, wheezing, and school absence in primary schools. Arch Dis Child. 1989; 64 (2): 246-251.

5. Korta-Murua J, Valverde-Molina J, Praena-Crespo M, Figuerola Mulet J, Rodríguez Fernández-Oliva CR, Rueda-Esteban S et al. La educación terapéutica en el asma. An Pediatr. 2007; 66 (5): 496-517.

6. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006; 117 (3): 549-556.

7. Maiman LA, Green LW, Gibson G, Mackenzie EJ. Education for self-treatment by adult asthmatics. JAMA J Am Med Assoc. 1979; 241 (18): 1919-1922.

8. Fm W, Jp G, Cm G, Nm C, Cj C. Intervenciones educativas para el asma infantil. 2006.

9. Cano-De La Cuerda R, Useros-Olmo AI, Muñoz-Hellín E. Eficacia de los programas de educación terapéutica en el paciente asmático. Arch Bronconeumol. 2010; 46 (11): 600-606.